New Kurma-Partner appointed The Venture Capital Company Kurma Partners, based in Paris and Munich, appointed Jean-Francois Rivassou as new Partner. more ➔
Change in Management Francesco Maria Lavino has been appointed as Chief Executive Officer of F2G Ltd., a biopharmaceutical company, based in UK and Austria, and specialised in fungal infections. more ➔
Abivax with new CMO At the beginning of March, Dr Sophie Biguenet has been the new Chief Medical Officer of Paris-based Abivax SA. more ➔
New CSO at Toxys B.V. Torben Osterlund is the new Chief Scientific Officer of the Dutch biotech company Toxys B.V., based in Leiden more ➔
New CEO of the Novo Nordisk Foundation Mads Krogsgaard Thomsen, CSO at Novo Nordisk, will take up the position as CEO of the Novo Nordisk Foundation effective from 1 March 2021. more ➔
Management changes at Abliva Lund-based Abliva AB named Dr Ellen Donnelly as its new CEO. At the beginning of February she succeeded Dr Erik Kinnmann, who had been CEO since 2018. more ➔
Swedish AlzeCure appoints CMO Märta Segerdahl will take over the position as Chief Medical Officer of Swedish AlzeCure Pharma AB on April. more ➔
Accure Therapeutics named new CMOSpanish Accure Therapeutics appoints Dr Rossella Medori as new Chief Medical officer. more ➔
Clariant new year, new CEOMuttenz-based Clariant announced the appointment of Conrad Keijzer as new Chief Executive Officer, more ➔
